The global biomaterials market is driven by the rising baby boomer population coupled with surging prevalence of deaths from chronic diseases.
Biomaterials Market has been growing at a moderate rate over the last five years on account of increasing prevalence of deaths from various chronic diseases, emerging technological innovations, rising number of baby boomer population, surging implantable devices market. During 2016-21, Biomaterials Market is anticipated to grow at an increased rate on the heels of high prevalence of chronic diseases coupled with emerging usage of biomaterials in various other applications. Moreover, increasing government aids and grants along with a series of technological innovations has been backing the market.
According to Azoth Analytics research report, “Global Biomaterials Market (By Type, By Application, By Region, By Country): Opportunities and Forecasts (2016-2021) – (By Value; By Material Type – Polymer, Ceramic, Metal; By Application - Orthopaedic, Cardiovascular, Plastic Surgery, Wound Care); By Region-North America, Europe, APAC, ROW; By Country – US, UK, Germany, Italy, Japan, China, India; Key Players – Strategy, Financial Performance)”, Global Biomaterials Market is projected to exhibit a CAGR of around 15.73% during 2016 - 2021.'
Few of the leading companies operating in Global Biomaterials Market are Royal DSM, Wright Medical Technology, Inc., Corbion N.V., Carpenter Technology Corporation, Zimmer Biomet Holdings, Inc., etc.
Scope of the Report
The report provides Segmentation by Material Type
- Polymer
- Ceramic
- Metal
The report provides Coverage by Application
- Orthopedic
- Cardiovascular
- Plastic Surgery
- Wound Care
- Others
The report provides coverage by Region
- North America
- Europe
- Asia Pacific
- ROW
The report provides coverage by Country
- United States
- United Kingdom
- Germany
- Italy
- Japan
- China
- India
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
2. Executive Summary
3. Strategic Recommendation
3.1. Focus on the APAC Region
3.2. Focus on developing plastic surgery biomaterials
3.3. Focus on ceramic biomaterials
4. Global Biomaterials Market: An Overview
4.1. Biomaterials Overview
4.2. Biomaterials Overview (By Material Type- Polymer Ceramics, Metal)
4.3. Biomaterials Overview (By Application- Cardiovascular, Orthopedic, Plastic Surgery, Wound Care)
5. Global Biomaterials Market: Growth and Forecast
5.1 Global Biomaterials Market
5.1.1. By Value (Historic 2011-15)
5.1.2. By Value (Forecast 2016E-2021F)
6. Biomaterials Market Size By Material Type (Polymer, Ceramics, Metal)
6.1 Global Biomaterials Market Size By Material Type: Breakdown
6.1.1. By Type-Actual (2015)
6.1.2. By Type-Forecast (2021)
6.2 Global Polymer Biomaterials Market
6.2.1. Market Size By Value (2011-2015)
6.2.2. Market Size By Value (2016-2021)
6.2.3. Global Polymer Biomaterials Market Share By Region By Value
6.2.3.1. Actual (2015)
6.2.3.2. Forecast (2021)
6.3 Global Metal Biomaterials Market
6.3.1. Market Size By Value (2011-2015)
6.3.2. Market Size By Value (2016-2021)
6.3.3. Global Metal Biomaterials Market Share By Region By Value
6.3.3.1. Actual (2015)
6.3.3.2. Forecast (2021)
6.4. Global Ceramic Biomaterials Market
6.4.1. Market Size By Value (2011-2015)
6.4.2. Market Size By Value (2016-2021)
6.4.3. Global Ceramic Biomaterial Market Share By Region By Value
6.4.3.1. Actual (2015)
6.4.3.2. Forecast (2021)
7. Biomaterials Market Size By Application (Orthopedic, Cardiovascular, Plastic Surgery, Wound Care, Others)
7.1. Global Biomaterials Market Share By Application: Breakdown
7.1.1. By Type-Actual (2015)
7.1.2. By Type-Forecast (2021)
7.2. Global Orthopedic Biomaterials Market Size
7.2.1. By Value (Historic 2011-15)
7.2.2. By Value (Forecast 2016E-2021F)
7.2.3. Global Orthopedic Biomaterials Market Share, By Region, By Value
7.2.3.1. Actual (2015)
7.2.3.2. Forecast (2021)
7.3. Global Cardiovascular Biomaterials Market Size
7.3.1. By Value (Historic 2011-15)
7.3.2. By Value (Forecast 2016E-2021F)
7.3.3. Global Cardiovascular Biomaterials Market Share, By Region, By Value
7.2.3.1. Actual (2015)
7.2.3.2. Forecast (2021)
7.4. Global Plastic Surgery Biomaterials Market Size
7.4.1. By Value (Historic 2011-15)
7.4.2. By Value (Forecast 2016E-2021F)
7.4.3. Global Plastic Surgery Biomaterials Market Share, By Region, By Value
7.4.3.1. Actual (2015)
7.4.3.2. Forecast (2021)
7.5. Global Wound Care Biomaterials Market Size
7.5.1. By Value (Historic 2011-15)
7.5.2. By Value (Forecast 2016E-2021F)
7.5.3. Global Wound Care Biomaterials Market Share, By Region, By Value
7.5.3.1. Actual (2015)
7.5.3.2. Forecast (2021)
8. Biomaterials Market Size By Region (North America, Europe, Asia Pacific, ROW)
8.1. Global Biomaterials Market Share By Region: Breakdown
8.1.1. Actual (2015)
8.1.2. Forecast (2021)
8.2. North America Biomaterials Market Size
8.2.1. By Value (Historic 2011-15)
8.2.2. By Value (Forecast 2016E-2021F)
8.2.3. North America Biomaterials Market Share, By Material Type, By Value
8.2.3.1. Actual (2015)
8.2.3.2. Forecast (2021)
8.2.4. North America Polymer Biomaterials Market Size
8.2.4.1. Market Size By Value (2011-2015)
8.2.4.2. Market Size By Value (2016-2021)
8.2.5. North America Metal Biomaterials Market Size
8.2.5.1. Market Size By Value (2011-2015)
8.2.5.2. Market Size By Value (2016-2021)
8.2.6. North America Ceramic Biomaterials Market Size
8.2.6.1. Market Size By Value (2011-2015)
8.2.6.2. Market Size By Value (2016-2021)
8.2.7. North America Biomaterials Market Share, By Application, By Value
8.2.7.1. Actual (2015)
8.2.7.2. Forecast (2021)
8.2.8. North America Orthopedic Biomaterials Market Size
8.2.8.1. Market Size By Value (2011-2015)
8.2.8.2. Market Size By Value (2016-2021)
8.2.9. North America Cardiovascular Biomaterials Market Size
8.2.9.1. Market Size By Value (2011-2015)
8.2.9.2. Market Size By Value (2016-2021)
8.2.10 North America Plastic Surgery Biomaterials Market Size
8.2.10.1. Market Size By Value (2011-2015)
8.2.10.2. Market Size By Value (2016-2021)
8.2.11 North America Wound Care Biomaterials Market Size
8.2.11.1 Market Size By Value (2011-2015)
8.2.11.2. Market Size By Value (2016-2021)
8.3. Europe Biomaterials Market Size
8.3.1. By Value (Historic 2011-15)
8.3.2. By Value (Forecast 2016E-2021F)
8.3.3. Europe Biomaterials Market Share, By Material Type, By Value
8.3.3.1. Actual (2015)
8.3.3.2. Forecast (2021)
8.3.4. Europe Polymer Biomaterials Market Size
8.3.4.1. Market Size By Value (2011-2015)
8.3.4.2. Market Size By Value (2016-2021)
8.3.5. Europe Metal Biomaterials Market Size
8.3.5.1. Market Size By Value (2011-2015)
8.3.5.2. Market Size By Value (2016-2021)
8.3.6. Europe Ceramic Biomaterials Market Size
8.3.6.1. Market Size By Value (2011-2015)
8.3.6.2. Market Size By Value (2016-2021)
8.3.7. Europe Biomaterials Market Share, By Application, By Value
8.3.7.1. Actual (2015)
8.3.7.2. Forecast (2021)
8.3.8. Europe Orthopedic Biomaterials Market Size
8.3.8.1. Market Size By Value (2011-2015)
8.3.8.2. Market Size By Value (2016-2021)
8.3.9. Europe Cardiovascular Biomaterials Market Size
8.3.9.1. Market Size By Value (2011-2015)
8.3.9.2. Market Size By Value (2016-2021)
8.3.10. Europe Plastic Surgery Biomaterials Market Size
8.3.10.1. Market Size By Value (2011-2015)
8.3.10.2. Market Size By Value (2016-2021)
8.3.11. Europe Wound Care Biomaterials Market Size
8.3.11.1. Market Size By Value (2011-2015)
8.3.11.2. Market Size By Value (2016-2021)
8.4. APAC Biomaterials Market Size
8.4.1. By Value (Historic 2011-15)
8.4.2. By Value (Forecast 2016E-2021F)
8.4.3. APAC Biomaterials Market Share, By Material Type, By Value
8.4.3.1. Actual (2015)
8.4.3.2. Forecast (2021)
8.4.4. APAC Polymer Biomaterials Market Size
8.4.4.1. Market Size By Value (2011-2015)
8.4.4.2. Market Size By Value (2016-2021)
8.4.5. APAC Metal Biomaterials Market Size
8.4.5.1. Market Size By Value (2011-2015)
8.4.5.2. Market Size By Value (2016-2021)
8.4.6. APAC Ceramic Biomaterials Market Size
8.4.6.1. Market Size By Value (2011-2015)
8.4.6.2. Market Size By Value (2016-2021)
8.4.7. APAC Biomaterials Market Share, By Application, By Value
8.4.7.1. Actual (2015)
8.4.7.2. Forecast (2021)
8.4.8. APAC Orthopedic Biomaterials Market Size
8.4.8.1. Market Size By Value (2011-2015)
8.4.8.2. Market Size By Value (2016-2021)
8.4.9. APAC Cardiovascular Biomaterials Market Size
8.4.9.1. Market Size By Value (2011-2015)
8.4.9.2. Market Size By Value (2016-2021)
8.4.10. APAC Plastic Surgery Biomaterials Market Size
8.4.10.1. Market Size By Value (2011-2015)
8.3.9.2. Market Size By Value (2016-2021)
8.4.11. APAC Wound Care Biomaterials Market Size
8.4.11.1. Market Size By Value (2011-2015)
8.4.11.2. Market Size By Value (2016-2021)
9. Country Analysis
9.1. United States Biomaterials Market Size
9.1.1. By Value (Historic 2011-15)
9.1.2. By Value (Forecast 2016E-2021F)
9.1.3. United States Biomaterials Market Share, By Material Type, By Value
9.1.3.1. Actual (2015)
9.1.3.2. Forecast (2021)
9.1.4. United States Polymer Biomaterials Market Size
9.1.4.1. Market Size By Value (2011-2015)
9.1.4.2. Market Size By Value (2016-2021)
9.1.5. United States Metal Biomaterials Market Size
9.1.5.1. Market Size By Value (2011-2015)
9.1.5.2. Market Size By Value (2016-2021)
9.1.6. United States Ceramic Biomaterials Market Size
9.1.6.1. Market Size By Value (2011-2015)
9.1.6.2. Market Size By Value (2016-2021)
9.2. Germany Biomaterials Market Size
9.2.1. By Value (Historic 2011-15)
9.2.1. By Value (Forecast 2016E-2021F)
9.2.2. Germany Biomaterials Market Share, By Material Type, By Value
9.2.2.1. Actual (2015)
9.2.2.2. Forecast (2021)
9.2.3. Germany Polymer Biomaterials Market Size
9.2.3.1. Market Size By Value (2011-2015)
9.2.3.2. Market Size By Value (2016-2021)
9.2.4. Germany Metal Biomaterials Market Size
9.2.4.1. Market Size By Value (2011-2015)
9.2.4.2 Market Size By Value (2016-2021)
9.2.5. Germany Ceramic Biomaterials Market Size
9.2.5.1. Market Size By Value (2011-2015)
9.2.5.2. Market Size By Value (2016-2021)
9.3. United kingdom Biomaterials Market Size
9.3.1. By Value (Historic 2011-15)
9.3.2. By Value (Forecast 2016E-2021F)
9.3.3. United Kingdom Biomaterials Market Share, By Material Type, By Value
9.3.3.1. Actual (2015)
9.3.3.2. Forecast (2021)
9.3.4. United Kingdom Polymer Biomaterials Market Size
9.3.4.1. Market Size By Value (2011-2015)
9.3.4.2. Market Size By Value (2016-2021)
9.3.5. United Kingdom Metal Biomaterials Market Size
9.3.5.1. Market Size By Value (2011-2015)
9.3.5.2 Market Size By Value (2016-2021)
9.3.6. United Kingdom Ceramic Biomaterials Market Size
9.3.6.1. Market Size By Value (2011-2015)
9.3.6.2. Market Size By Value (2016-2021)
9.4. Italy Biomaterials Market Size
9.4.1. By Value (Historic 2011-15)
9.4.2. By Value (Forecast 2016E-2021F)
9.4.3. Italy Biomaterials Market Share, By Material Type, By Value
9.4.3.1. Actual (2015)
9.4.3.2. Forecast (2021)
9.4.4. Italy Polymer Biomaterials Market Size
9.4.4.1. Market Size By Value (2011-2015)
9.4.4.2. Market Size By Value (2016-2021)
9.4.5. Italy Metal Biomaterials Market Size
9.4.5.1. Market Size By Value (2011-2015)
9.4.5.2 Market Size By Value (2016-2021)
9.4.6. Italy Ceramic Biomaterials Market Size
9.4.6.1. Market Size By Value (2011-2015)
9.4.6.2. Market Size By Value (2016-2021)
9.7. Japan Biomaterials Market Size
9.7.1. By Value (Historic 2011-15)
9.7.2. By Value (Forecast 2016E-2021F)
9.7.3. Japan Biomaterials Market Share, By Material Type, By Value
9.7.3.1. Actual (2015)
9.7.3.2. Forecast (2021)
9.7.4. Japan Polymer Biomaterials Market Size
9.7.4.1. Market Size By Value (2011-2015)
9.7.4.2. Market Size By Value (2016-2021)
9.7.5. Japan Metal Biomaterials Market Size
9.7.5.1. Market Size By Value (2011-2015)
9.7.5.2 Market Size By Value (2016-2021)
9.7.6. Japan Ceramic Biomaterials Market Size
9.7.6.1. Market Size By Value (2011-2015)
9.7.6.2. Market Size By Value (2016-2021)
9.8. China Biomaterials Market Size
9.8.1. By Value (Historic 2011-15)
9.8.2. By Value (Forecast 2016E-2021F)
9.8.3. China Biomaterials Market Share, By Material Type, By Value
9.8.3.1. Actual (2015)
9.8.3.2. Forecast (2021)
9.8.4. China Polymer Biomaterials Market Size
9.8.4.1. Market Size By Value (2011-2015)
9.8.4.2. Market Size By Value (2016-2021)
9.8.5. China Metal Biomaterials Market Size
9.8.5.1. Market Size By Value (2011-2015)
9.8.5.2 Market Size By Value (2016-2021)
9.8.6. China Ceramic Biomaterials Market Size
9.8.6.1. Market Size By Value (2011-2015)
9.8.6.2. Market Size By Value (2016-2021)
9.9. India Biomaterials Market Size
9.9.1. By Value (Historic 2011-15)
9.9.2. By Value (Forecast 2016E-2021F)
9.9.3. India Biomaterials Market Share, By Material Type, By Value
9.9.3.1. Actual (2015)
9.9.3.2. Forecast (2021)
9.9.4. India Polymer Biomaterials Market Size
9.9.4.1. Market Size By Value (2011-2015)
9.9.4.2. Market Size By Value (2016-2021)
9.8.5. India Metal Biomaterials Market Size
9.9.5.1. Market Size By Value (2011-2015)
9.9.5.2 Market Size By Value (2016-2021)
9.9.6. India Ceramic Biomaterials Market Size
9.9.6.1. Market Size By Value (2011-2015)
9.9.6.2. Market Size By Value (2016-2021)
10. Market Dynamics
10.1. Drivers
10.2. Challenges
10.3. Trends
11. Policy and Regulatory Landscape
12. Competitive Landscape
12.1. Company Profiles
12.1. Evonik Industries
12.2. Bayer Healthcare AG
12.3. Zimmer Biomet Holdings Inc.
12.4. Wright Medical Group.
12.5. Koninklijke DSM N.V.
12.6. Basf SE
12.7. Corbion N.V.
12.8. Carpenter Technology Corporation
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.